CD292 Polyclonal Antibody

    • Catalog No.:YT5528
    • Applications:WB,ELISA
    • Reactivity:Human
    • Description
    • Gene Name:
    • BMPR1A
    • Protein Name:
    • Bone morphogenetic protein receptor type-1A
    • Human Gene Id:
    • 657
    • Human Swiss Prot No:
    • P36894
    • Mouse Swiss Prot No:
    • P36895
    • Immunogen:
    • The antiserum was produced against synthesized peptide derived from the N-terminal region of human BMPR1A. AA range:1-50
    • Specificity:
    • CD292 Polyclonal Antibody detects endogenous levels of CD292 protein.
    • Formulation:
    • Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
    • Source:
    • Rabbit
    • Dilution:
    • Western Blot: 1/500 - 1/2000. ELISA: 1/20000. Not yet tested in other applications.
    • Purification:
    • The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
    • Concentration:
    • 1 mg/ml
    • Storage Stability:
    • -20°C/1 year
    • Other Name:
    • BMPR1A; ACVRLK3; ALK3; Bone morphogenetic protein receptor type-1A; BMP type-1A receptor; BMPR-1A; Activin receptor-like kinase 3; ALK-3; Serine/threonine-protein kinase receptor R5; SKR5; CD292
    • MolecularWeight(Da):
    • 60198
    • Observed Band(KD):
    • 60
    • Background:
    • bone morphogenetic protein receptor type 1A(BMPR1A) Homo sapiens The bone morphogenetic protein (BMP) receptors are a family of transmembrane serine/threonine kinases that include the type I receptors BMPR1A and BMPR1B and the type II receptor BMPR2. These receptors are also closely related to the activin receptors, ACVR1 and ACVR2. The ligands of these receptors are members of the TGF-beta superfamily. TGF-betas and activins transduce their signals through the formation of heteromeric complexes with 2 different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Type II receptors bind ligands in the absence of type I receptors, but they require their respective type I receptors for signaling, whereas type I receptors require their respective type II receptors for ligand binding. [provided by RefSeq, Jul 2008],
    • Function:
    • catalytic activity:ATP + [receptor-protein] = ADP + [receptor-protein] phosphate.,cofactor:Magnesium or manganese.,disease:A microdeletion of chromosome 10q23 involving BMPR1A and PTEN is a cause of chromosome 10q23 deletion syndrome [MIM:612242]. This syndrome shows overlapping features of the following three disorders: Bannayan-Zonana syndrome, Cowden disease and juvenile polyposis syndrome. The 10q23 microdeletion is also found in patients manifesting juvenile polyposis of infancy without cognitive disability. Juvenile polyposis of infancy is characterized by the appearance of extensive gastrointestinal juvenile hamartomatous polyposis in the first months of life.,disease:Defects in BMPR1A are a cause of Cowden disease (CD) [MIM:158350]. CD is an autosomal dominant cancer syndrome characterized by multiple hamartomas and by a high risk for breast, thyroid and endometrial cancers.,dise
    • Subcellular Location:
    • plasma membrane,caveola,external side of plasma membrane,integral component of membrane,dendrite,neuronal cell body,HFE-transferrin receptor complex,
    • Expression:
    • Epithelium,Placenta,Testis,
    • Products Images
    • Western Blot analysis of SKOV3 cells using CD292 Polyclonal Antibody.. Secondary antibody(catalog#:RS0002) was diluted at 1:20000